Superinfection of HIV-2-preinfected macaques after rectal exposure to a primary isolate of SIVmac251

Virology

Volumn 221, Issue 2, 1996, Pages 260-270

  Wakrim, Lahcen ^a   Le Grand, Roger ^a   Vaslin, Bruno ^a   Chéret, Arnaud ^a   Matheux, Franck ^a   Theodoro, Frederic ^a   Roques, Pierre ^a   Nicol Jourdain, Isabelle ^a   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RECTUM MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS ISOLATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0030586061     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0375     Document Type: Article

References (51)

1. Almond, N., Kent, K., Cranage, M., Rud, E., Clarke, B., and Stott, E. J. (1995). Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345(8961), 1342-1344.
2. Arthur, L. O., Bess, J. W., Sowder, R. C., II, Benveniste, R. E., Mann, D. L., Chermann, J.-C., and Henderson, L. E. (1992). Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science 258, 1935-1938.
3. Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
4. Baskin, G. B., Murphey-Corb, M., Watson, E. A., and Martin, L. N. (1988). Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/Delta. Vet. Pathol. 25, 456-467.
5. Benveniste, O., Vaslin, B., Le Grand, R., Fouchet, P., Omessa, V., Theodora, F., Fretier, P., Clayette, P., Boussin, F., and Dormont, D. (1996). Interleukin 1β, interleukin 6, tumor necrosis factor α and interleukin 10 responses in peripheral blood mononuclear cells of cynomolgus macaques during acute infection with SIVmac251. AIDS Res. Hum. Retroviruses 12(3), 241-250.
6. Bergmeier, L. A., Walker, J., Tao, L., Cranage, M., and Lehner, T. (1994). Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus. Immunology 83(2), 213-220.
7. Berman, P. W., Gregory, T. G., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K., and Eichberg, J. W. (1990). Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345, 622-625.
8. Bruck, C., Thiriart, C., Fabry, L., Francotte, M., Pala, P., Van Opstal, O., Culp, J., Rosenberg, M., De Wilde, M., Heidt, P., and Henney, J. (1992). HIV-1 neutralizing antibody titers induced by vaccination correlate with protection from infection and decreased virus load in chimpanzees. In "Retroviruses of Human A.I.D.S. and Related Animal Diseases: Septième Colloque des Cent Gardes, Marnes-La-Coquette, France" (M. G. a. L. Valette, Ed.), pp. 227-233. Fondation Marcel Merieux, Lyon.
9. Bruck, C., Thiriart, C., Fabry, L., Francotte, M., Pala, P., Van Opstal, O., Culp, J., Rosenberg, M., De Wilde, M., Heidt, P., and Henney, J. (1994). HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine 12(12), 1141-1148.
10. Chakrabarti, L., Guyader, M., Alizon, M., Daniel, M. D., Desrosiers, R. C., Tiollais, P., and Sonigo, P. (1987). Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 328, 543-547.
11. Cranage, M. P., Polyanskaya, N., McBride, B., Cook, N., Ashworth, L. A., Dennis, M., Baskerville, A., Greenaway, P. J., Corcoran, T., Kitchin, P., Rose, J., Murphey-Corb, M., Desrosiers, R. C., Stott, E. J., and Farrar, G. H. (1993). Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 9(1), 13-22.
12. Daniel, M. D., Kirchoff, F., Czajak, S. C., Sehgal, P. K., and Desrosiers, R. C. (1992). Protective effects of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
13. Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Kanki, P. K., Essex, M., and Desrosiers, R. C. (1985). Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques. Science 228, 1200-1204.
14. Desrosiers, R. C. (1990). The simian immunodeficiency viruses. Annu. Rev. Immunol. 8, 557-578.
15. Desrosiers, R. C., Daniel, M. D., and Li, Y. (1989). HIV-related lentiviruses of nonhuman primates. AIDS Res. Hum. Retroviruses 5, 465-473.
16. Dormont, D., Le Grand, R., Cranage, M., Greenaway, P., Hunsman, G., Stahl-Hennig, C., Rossi, G., Verani, P., Stott, J., Kitchin, P., Osterhaus, A., Vries, P., Kurth, R., Norley, S., Heeney, J., Biberfeld, G., and Putkonen, P. (1995). Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: Comparison of adjuvants, doses and challenge viruses. Vaccine 13, 295-300.
17. Dormont, D., Livartowski, J., Chamaret, S., Guetard, D., Henin, D., Levagueresse, R., Van der Moortelle, P. F., Larke, B., Gourmelon, P., Vazeux, R., Metivier, H., Rageat, J., Court, L., Hauw, J. J., and Montagnier, L. (1989). HIV-2 in rhesus monkeys: Serological, virological and clinical results. Intervirology 30(Suppl. 1), 59-65.
18. Dormont, D., Liwartowski, J., Vogt, G., Chamaret, S., Nicol, I., Dwyer, D., Lebon, P., Guetard, D., and Montagnier, L. (1990). Second in vivo passage of HIV-2 in rhesus monkeys. In "Animal Models in AIDS" (H. Schellekens and M. C. Horzinec, Eds.). Elsevier, Amsterdam.
19. Girard, M., Kieny, M. P., Pinter, A., Barré-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., Muchmore, E., Ronco, J., Kaczorek, M., Gomard, E., Gluckman, J. C., and Fultz, P. (1991). Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88, 542-546.
20. Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L., and Alizon, M. (1987). Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326, 662-669.
21. Hulskotte, E. G. J., Geretti, A. M., Siebelink, K. H. J., Vanamerongen, G., Cranage, M. P., Rud, E. W., Norley, S. G., Devries, P., and Osterhaus, A. D. M. E. (1995). Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). J. Virol. 69(10), 6289-6296.
22. Johnson, P. R., Montefiori, D. C., Goldstein, S., Hamm, T. E., Zhou, J., Kitov, S., Haigwood, N. L., Misher, L., London, W. T., Gerin, J. L., Allison, A., Purcell, R. H., Chanock, R. M., and Hirsch, V. M. (1992). Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc. Natl. Acad. Sci. USA 89(6), 2175-2179.
23. Kärber, G. (1931). Beitrag zur kollektiven Behandlung Pharmakologischer Reihenvesuche. Arch. Exp. Pathol. Pharmakol. 162, 956-959.
24. Kieny, M. P., Aubertin, A. M., Benavente, A., Schmitt, D., Dott, K., Beyer, C., Kirn, A., Fischer, F., Hurtrel, B., Rvière, Y., Venet, A., and Mehtali, M. (1993). Protection of monkeys against SIV infection with live attenuated viruses. In "Retroviruses of Human A.I.D.S. and Related Animal Diseases: Huitième Colloque des Cent Gardes, Marnes-La-Coquette, France" (M. G. a. L. Valette, Ed.), pp. 211-218. Fondation Marcel Merieux, Lyon.
25. Langlois, A. J., Weinhold, K. J., Matthews, T. J., Greenberg, M. L., and Bolognesi, D. P. (1992). Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res. Hum. Retroviruses 8(9), 1641-1652.
26. Le Grand, R., and Dormont, D. (1993). Infection of macaques after a traumatic rectal exposure to SIVmac251. In "Retroviruses of Human A.I.D.S. and Related Animal Diseases: Huitième Colloque des Cent Gardes, Marnes-La-Coquette, France" (M. G. a. L. Valette, Ed.), pp. 157-160. Fondation Marcel Merieux, Lyon.
27. Le Grand, R., Clayette, P., Noack, O., Vaslin, B., Théodora, F., Michel, G., Roques, P., and Dormont, D. (1994). An animal model for antilentiviral therapy: Effect of zidovudine on viral load during acute infection after exposure of macaques to simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 10, 1279-1287.
28. Le Grand, R., Vaslin, B., Vogt, G., Roques, P., Humbert, D., Aubertin, A. M., and Dormont, D. (1992). AIDS vaccine developments. Nature 355, 684.
29. Letvin, N. L., Daniel, M. D., Sehgal, P. K., Desrosiers, R. C., Hunt, R. D., Waldron, L. M., MacKey, J. J., Schmidt, D. K., Chalifoux, L. V., and King, N. W. (1985). Induction of AIDS-like disease in macaques monkeys with T-cell tropic retrovirus STLV-III. Science 230, 71-73.
30. Lohman, B. L., McChesney, M. B., Miller, C. J., McGowan, E., Joye, S. M., Van, R. K., Reay, E., Antipa, L., Pedersen, N. C., and Marthas, M. L. (1994). A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68(11), 7021-7029.
31. Makoschey, B., Faisst, A. C., Le Grand, R., Coulibaly, C., Stahl-Hennig, C., and Hunsmann, G. (1994). SIV-and HIV-2-neutralising antibodies in infected macaques measured by a novel and simple neutralisation test based on a non-commercial antigen-ELISA. J. Virol. Methods 50(1-3), 257-268.
32. Marthas, M., Sutjipto, S., Miller, C., Higgins, J., Unger, R., Kiyono, H., McGhee, J., Marx, P., and Pederson, N. (1992). Efficacy of Live-Attenuated and Whole Inactivated Simian Immunodeficiency Virus Vaccines against Intravenous and Intravaginal Challenge, pp. 117-122. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Marthas, M. L., Sutjipto, S., Higgins, J., Iohman, B., Torten, J., Luciw, P. A., Marx, P. A., and Pedersen, N. C. (1990). Immunization with a live attenauted SIV prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Viol. 64(8), 3694-3700.
34. Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., and Eldridge, J. H. (1993). Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260, 1323-1327.
35. Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D., and Nedrud, J. G. (1992). Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89(15), 6901-6905.
36. McClure, H., Anderson, D., Fultz, P., Ansari, A., Lockwood, E., and Brodie, A. (1989). Spectrum of disease in macaque monkey chronically infected with SIV/SMM. Vet. Immunol. Immunopathol. 21, 13-24.
37. Miller, J. C., Kanf, D. W., Marthas, M., Moldoveanu, Z., Kiyono, H., Marx, P., Eldridge, J. H., Mestecky, J., and McGhee, J. R. (1992). Genital secretory immune response to chronic simian immunodeficiency virus (SIV) infection: A comparison between intravenously and genitally inoculated rhesus macaques. Clin. Exp. Immunol. 88, 520-526.
38. Mills, K. H., Page, M., Chan, W. L., Kitchin, P., Stott, E. J., Taffs, F., Jones, W., Rose, J., Ling, C., Silvera, P., et al. (1992). Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins. J. Med. Primatol. 21(2-3), 50-58.
39. Murphey-Corb, M., Martin, L. N., Davison-Fairburn, B., Montelaro, R. C., Miller, M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y., Putney, S. D., Allison, A. C., and Eppstein, D. A. (1989). A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297.
40. Nicol-Jourdain, I., Boussin, F., Bäyon-Auboyer, M. H., Vogt, G., Fossati, I., and Dormont, D., Eds. (1993). HIV-2 in rhesus monkeys: Five year follow-up. In "Animal Models of HIV and Other Retroviral Infections" (P. Racz, N. L. Letvin, and J. C. Gluckman, Eds.). Karger, Basel.
41. Petry, H., Dittmer, U., Stahl, H. C., Coulibaly, C., Makoschey, B., Fuchs, D., Wachter, H., Tolle, T., Morys, W. C., Kaup, F. J., Jurkiewicz, E., Luke, W., and Hunsmann, G. (1995). Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J. Virol. 69(3), 1564-1574.
42. Putkonen, P., Nilsson, C., Walther, L., Ghavamzadeh, L., Hild, K., Broliden, K., Biberfeld, G., and Thorsetnsson, R. (1994). Efficacy of inactivated whole HIV-2 vaccines with various adjuvants in cynomolgus monkeys. J. Med. Primatol. 23, 89-94.
43. Putkonen, P., Thorstensson, R., Albert, J., Hild, K., Norrby, E., Biberfeld, P., and Biberfeld, G. (1990). Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS 4, 783-789.
44. Putkonen, P., Thorstensson, R., Walther, L., Albert, J., Akerblom, L., Granquist, O., Wadell, G., Norrby, E., and Biberfeld, G. (1991). Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res. Hum. Retroviruses 7(3), 271-277.
45. Putkonen, P., Walther, L., Zhang, Y. J., Li, S. L., Nilsson, C., Albert, J., Biberfeld, P., Thorstensson, R., and Biberfeld, G. (1995). Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat. Med. 1(9), 914-918.
46. Spouge, J. L. (1992). Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc. Natl. Acad. Sci. USA 89, 7581-7585.
47. ben, a novel HIV-2 isolate. AIDS 4, 611-617.
48. Stahl-Hennig, C., Voss, G., Dittmer, U., Coulibaly, C., Petry, H., Makoschey, B., Cranage, M. P., Aubertin, A. M., Lüke, W., and Hunsmann, G. (1993). Protection of monkeys by split vaccine against SIV-mac depends upon biological properties of the challenge virus. AIDS 7, 787-795.
49. Stahl-Hennig, C., Voss, G., Nick, S., Petry, H., Fuchs, D., Wachter, H., Coulibaly, C., Lüke, W., and Hunsmann, G. (1992). Immunization with Tween-ether-treated SIV absorbed onto aluminum hydroxide protects monkeys against experimental SIV infection. Virology 186, 588-596.
50. Stott, E. J. (1991). Anti-cell antibody in macaques. Nature 353(6343), 393. [Letter] [See comments]
51. Sutjipto, S., Pedersen, N. C., Miller, C. J., Gardner, M. B., Hanson, C. V., Gettie, A., Jennings, M., Higgins, J., and Marx, P. A. (1990). Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J. Virol. 64, 2290-2297.